Evaluation of Cancer Care Coordination in the National Cancer Institutes Community Cancer Center Programs
|ClinicalTrials.gov Identifier: NCT01346280|
Recruitment Status : Completed
First Posted : May 2, 2011
Last Update Posted : October 6, 2017
-Coordinated cancer care provided by doctors, nurses, social workers, and other care providers is believed to improve patient and physician satisfaction and patient evaluation for enrollment in clinical trials. But no research has been done to show that this approach improves patient experiences and outcomes. Researchers want to study this model to better understand how it can improve cancer treatment and patient outcomes.
- To assess the relationship between coordinated care and cancer treatment processes and outcomes.
- Individuals who are at least 18 years of age. Those who take part must have been diagnosed with colon, rectal, or non-small-cell lung cancer. They also must be receiving or have been treated at one of the 16 NCI Community Cancer Center program sites.
- Researchers will collect medical records data from participants.
- Participants will complete a questionnaire about 8 weeks after the end of all planned cancer treatment. They will be asked questions about their experience with coordinated cancer care. They will also be asked for any comments or concerns they had during and after treatment.
- No treatment or additional tests will be provided as part of this protocol.
|Condition or disease|
|Non-Small Cell Lung Cancer (Stage III) Colon Cancer (Stage II &Amp; III) Rectal Cancer (Stage III)|
Show Detailed Description
|Study Type :||Observational|
|Estimated Enrollment :||1695 participants|
|Official Title:||Quality of Care: The Impact of Multidisciplinary Care on Processes and Outcomes of Cancer Care|
|Study Start Date :||April 16, 2011|
|Estimated Study Completion Date :||October 5, 2015|
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01346280
|United States, Maryland|
|National Cancer Institute (NCI), 9000 Rockville Pike|
|Bethesda, Maryland, United States, 20892|
|Principal Investigator:||Kathleen Castro, R.N.||National Cancer Institute (NCI)|